{
  "PMC": "9166156",
  "DOI": "10.1007/s12274-022-4385-4",
  "PMID": "35692441",
  "PMCID": "PMC9166156",
  "title": "Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development.",
  "year": 2022,
  "source_url": "https://europepmc.org/article/PMC/PMC9166156",
  "source": "MED",
  "abstract_text": "Proteins have been widely used in the biomedical field because of their well-defined architecture, accurate molecular weight, excellent biocompatibility and biodegradability, and easy-to-functionalization. Inspired by the wisdom of nature, increasing proteins/peptides that possess self-assembling capabilities have been explored and designed to generate nanoassemblies with unique structure and function, including spatially organized conformation, passive and active targeting, stimuli-responsiveness, and high stability. These characteristics make protein/peptide-based nanoassembly an ideal platform for drug delivery and vaccine development. In this review, we focus on recent advances in subsistent protein/peptide-based nanoassemblies, including protein nanocages, virus-like particles, self-assemblable natural proteins, and self-assemblable artificial peptides. The origin and characteristics of various protein/peptide-based assemblies and their applications in drug delivery and vaccine development are summarized. In the end, the prospects and challenges are discussed for the further development of protein/peptide-based nanoassemblies.",
  "full_text": "pmc Nano Res Nano Res Nano Research 1998-0124 1998-0000 Tsinghua University Press Beijing 9166156 35692441 4385 10.1007/s12274-022-4385-4 Review Article Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development Liu Taiyu Li Lu Cheng Cheng He Bingfang Jiang Tianyue tjiang@njtech.edu.cn grid.412022.7 0000 0000 9389 5210 School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816 China 4 6 2022 2022 15 8 7267 7285 29 1 2022 31 3 2022 1 4 2022 © Tsinghua University Press 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. Proteins have been widely used in the biomedical field because of their well-defined architecture, accurate molecular weight, excellent biocompatibility and biodegradability, and easy-to-functionalization. Inspired by the wisdom of nature, increasing proteins/peptides that possess self-assembling capabilities have been explored and designed to generate nanoassemblies with unique structure and function, including spatially organized conformation, passive and active targeting, stimuli-responsiveness, and high stability. These characteristics make protein/peptide-based nanoassembly an ideal platform for drug delivery and vaccine development. In this review, we focus on recent advances in subsistent protein/peptide-based nanoassemblies, including protein nanocages, virus-like particles, self-assemblable natural proteins, and self-assemblable artificial peptides. The origin and characteristics of various protein/peptide-based assemblies and their applications in drug delivery and vaccine development are summarized. In the end, the prospects and challenges are discussed for the further development of protein/peptide-based nanoassemblies. Keywords drug delivery vaccine protein/peptide self-assembly targeting controlled release issue-copyright-statement © Tsinghua University Press 2022 Acknowledgements This work was supported by the National Key Research and Development Program of China (No. 2019YFA0905200), the National Natural Science Foundation of China (No. 82072045), and the Natural Science Foundation of Jiangsu Province of China for Excellent Young Scholars (No. BK20190084). References [1] Hoonjan M Sachdeva G Chandra S Kharkar P S Sahu N Bhatt P Investigation of HSA as a biocompatible coating material for arsenic trioxide nanoparticles Nanoscale 2018 10 8031 8041 10.1039/C7NR09503A 29670967 [2] Krauss I R Picariello A Vitiello G De Santis A Koutsioubas A Houston J E Fragneto G Paduano L Interaction with human serum proteins reveals biocompatibility of phosphocholine-functionalized spions and formation of albumin-decorated nanoparticles Langmuir 2020 36 8777 8791 10.1021/acs.langmuir.0c01083 32575987 [3] Wang L R Lin H Y Chi X Q Sun C J Huang J Q Tang X X Chen H M Luo X J Yin Z Y Gao J H A self-assembled biocompatible nanoplatform for multimodal MR/fluorescence imaging assisted photothermal therapy and prognosis analysis Small 2018 14 1801612 10.1002/smll.201801612 [4] Pan G H Ni J Wei Y F Yu G L Gentz R Dixit V M An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 1997 277 815 818 10.1126/science.277.5327.815 9242610 [5] Tan C Y Ban H Kim Y H Lee S K The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrial-independent/extrinsic pathway of cellular apoptosis Mol. Cells 2009 27 703 10.1007/s10059-009-0090-3 [6] Li J Y Paragas N Ned R M Qiu A D Viltard M Leete T Drexler I R Chen X Sanna-Cherchi S Mohammed F Scara5 is a ferritin receptor mediating non-transferrin iron delivery Dev. Cell 2009 16 35 46 10.1016/j.devcel.2008.12.002 19154717 [7] Liu J L Chen B X Zhao B Luo X B Li J F Xie Y T Li B L Chen H Y Zhao M Y Yan H D Effect of hirudin on arterialized venous flap survival in rabbits Biomed. Pharmacother. 2021 142 111981 10.1016/j.biopha.2021.111981 34364044 [8] Ki M R Kim J K Kim S H Nguyen T K M Kim K H Pack S P Compartment-restricted and rate-controlled dual drug delivery system using a biosilica-enveloped ferritin cage J. Ind. Eng. Chem. 2020 81 367 374 10.1016/j.jiec.2019.09.027 [9] Murata M Narahara S Kawano T Hamano N Piao J S Kang J H Ohuchida K Murakami T Hashizume M Design and function of engineered protein nanocages as a drug delivery system for targeting pancreatic cancer cells via neuropilin-1 Mol. Pharm. 2015 12 1422 1430 10.1021/mp5007129 25811429 [10] Reuter L J Shahbazi M A Mäkilä E M Salonen J J Saberianfar R Menassa R Santos H A Joensuu J J Ritala A Coating nanoparticles with plant-produced transferrin-hydrophobin fusion protein enhances their uptake in cancer cells Bioconjug. Chem. 2017 28 1639 1648 10.1021/acs.bioconjchem.7b00075 28557453 [11] Lucon J Abedin M J Uchida M Liepold L Jolley C C Young M Douglas T A click chemistry based coordination polymer inside small heat shock protein Chem. Commun. 2010 46 264 266 10.1039/B920868B [12] Varpness Z Suci P A Ensign D Young M J Douglas T Photosensitizer efficiency in genetically modified protein cage architectures Chem. Commun. 2009 3726 3728 [13] Gillitzer E Willits D Young M Douglas T Chemical modification of a viral cage for multivalent presentation Chem. Commun. 2002 2390 2391 [14] Ding D Yang C Lv C Li J Tan W H Improving tumor accumulation of aptamers by prolonged blood circulation Anal. Chem. 2020 92 4108 4114 10.1021/acs.analchem.9b05878 32037790 [15] Brandt M Cardinale J Giammei C Guarrochena X Happl B Jouini N Mindt T L Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders Nucl. Med. Biol. 2019 70 46 52 10.1016/j.nucmedbio.2019.01.006 30831342 [16] Chen X Ling X Zhao L L Xiong F Hollett G Kang Y Barrett A Wu J Biomimetic shells endow sub-50 nm nanoparticles with ultrahigh paclitaxel payloads for specific and robust chemotherapy ACS. Appl. Mater. Interfaces 2018 10 33976 33985 10.1021/acsami.8b11571 30203956 [17] Wang M Y Zhang L Cai Y F Yang Y Qiu L P Shen Y T Jin J Zhou J Chen J H Bioengineered human serum albumin fusion protein as target/enzyme/pH three-stage propulsive drug vehicle for tumor therapy ACS Nano 2020 14 17405 17418 10.1021/acsnano.0c07610 33202141 [18] Desai N Trieu V Yao Z W Louie L Ci S Yang A Tao C L De T Beals B Dykes D Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel Clin. Cancer Res. 2006 12 1317 1324 10.1158/1078-0432.CCR-05-1634 16489089 [19] Wang D F Liang N Kawashima Y Cui F D Yan P F Sun S P Biotin-modified bovine serum albumin nanoparticles as a potential drug delivery system for paclitaxel J. Mater. Sci 2019 54 8613 8626 10.1007/s10853-019-03486-9 [20] Das R P Singh B G Kunwar A Ramani M V Subbaraju G V Hassan P A Priyadarsini K I Tuning the binding, release and cytotoxicity of hydrophobic drug by bovine serum albumin nanoparticles: Influence of particle size Colloids Surf. B Biointerfaces 2017 158 682 688 10.1016/j.colsurfb.2017.07.048 28783613 [21] Gong T Tan T T Zhang P Li H H Deng C F Huang Y Gong T Zhang Z R Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis Biomaterials 2020 258 120296 10.1016/j.biomaterials.2020.120296 32781326 [22] Nosrati H Abbasi R Charmi J Rakhshbahar A Aliakbarzadeh F Danafar H Davaran S Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells Int. J. Biol. Macromol. 2018 117 1125 1132 10.1016/j.ijbiomac.2018.06.026 29885392 [23] Gaowa A Horibe T Kohno M Sato K Harada H Hiraoka M Tabata Y Kawakami K Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo J. Controlled Release 2014 176 1 7 10.1016/j.jconrel.2013.12.021 [24] Chen X J Zou J F Zhang K Zhu J J Zhang Y Zhu Z H Zheng H Y Li F Z Piao J G Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment Acta. Pharm. Sin. B 2021 11 271 282 10.1016/j.apsb.2020.08.009 33532192 [25] Zhou H He G Sun Y B Wang J G Wu H T Jin P Zha Z Cryptobiosis-inspired assembly of “AND” logic gate platform for potential tumor-specific drug delivery Acta Pharm. Sin. B 2021 11 534 543 10.1016/j.apsb.2020.08.007 33643829 [26] He G Chen S Xu Y J Miao Z H Ma Y Qian H S Lu Y Zha Z B Charge reversal induced colloidal hydrogel acts as a multi-stimuli responsive drug delivery platform for synergistic cancer therapy Mater. Horiz. 2019 6 711 716 10.1039/C9MH00020H [27] Cheng W Y Wang B L Zhang C Y Dong Q N Qian J J Zha L Chen W D Hong L F Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles J. Pharm. Pharmacol. 2019 71 1626 1634 10.1111/jphp.13151 31468524 [28] Bao X Y Qian K Yao P Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice J. Nanobiotechnol. 2020 18 67 10.1186/s12951-020-00619-0 [29] Shinde P Agraval H Singh A Yadav U C S Kumar U Synthesis of luteolin loaded zein nanoparticles for targeted cancer therapy improving bioavailability and efficacy J. Drug. Deliv. Sci. Technol. 2019 52 369 378 10.1016/j.jddst.2019.04.044 [30] Alqahtani M S Syed R Alshehri M Size-dependent phagocytic uptake and immunogenicity of gliadin nanoparticles Polymers 2020 12 2576 10.3390/polym12112576 33147852 [31] Yang Y Y Zhang M Liu Z P Wang K Yu D G Meletin sustained-release gliadin nanoparticles prepared via solvent surface modification on blending electrospraying Appl. Surf. Sci. 2018 434 1040 1047 10.1016/j.apsusc.2017.11.024 [32] Qian X P Ge L Yuan K J Li C Zhen X Cai W B Cheng R S Jiang X Q Targeting and microenvironment-improving of phenylboronic acid-decorated soy protein nanoparticles with different sizes to tumor Theranostics 2019 9 7417 7430 10.7150/thno.33470 31695777 [33] Farooq M A Aquib M Ghayas S Bushra R Haleem Khan D Parveen A Wang B Whey protein: A functional and promising material for drug delivery systems recent developments and future prospects Polym. Adv. Technol. 2019 30 2183 2191 10.1002/pat.4676 [34] Castro M A A Alric I Brouillet F Peydecastaing J Fullana S G Durrieu V Spray-dried succinylated soy protein microparticles for oral ibuprofen delivery AAPS PharmSciTech 2019 20 79 10.1208/s12249-018-1250-6 30635750 [35] Tang J H Zhou J P Chen F H Sun T T Kuang W J Feng R X Synthesis, characterization and drug-loading capacity of novel amphiphilic amino acid copolymer J. China Pharm. Univ. 2012 43 211 215 [36] Loureiro A Nogueira E Azoia N G Sárria M P Abreu A S Shimanovich U Rollett A Härmark J Hebert H Guebitz G Size controlled protein nanoemulsions for active targeting of folate receptor positive cells Colloids Surf. B Biointerfaces 2015 135 90 98 10.1016/j.colsurfb.2015.06.073 26241920 [37] Yang P P Zhang K He P P Fan Y Gao X J Gao X F Chen Z M Hou D Y Li Y Yi Y A biomimetic platelet based on assembling peptides initiates artificial coagulation Sci. Adv. 2020 6 eaaz4107 10.1126/sciadv.aaz4107 32766439 [38] Bao C Y Yin Y H Zhang Q Synthesis and assembly of laccase-polymer giant amphiphiles by self-catalyzed CuAAC click chemistry Biomacromolecules 2018 19 1539 1551 10.1021/acs.biomac.8b00087 29562131 [39] Mohammad-Beigi H Shojaosadati S A Morshedi D Arpanaei A Marvian A T Preparation and in vitro characterization of gallic acid-loaded human serum albumin nanoparticles J. Nanopart. Res. 2015 17 167 10.1007/s11051-015-2978-5 [40] Li W Garringer H J Goodwin C B Richine B Acton A VanDuyn N Muhoberac B B Irimia-Dominguez J Chan R J Peacock M Systemic and cerebral iron homeostasis in ferritin knock-out mice PLoS One 2015 10 e0117435 10.1371/journal.pone.0117435 25629408 [41] Thompson K Menzies S Muckenthaler M Torti F M Wood T Torti S V Hentze M W Beard J Connor J Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress J. Neurosci. Res. 2003 71 46 63 10.1002/jnr.10463 12478613 [42] Pieters B J G E Van Eldijk M B Nolte R J M Mecinović J Natural supramolecular protein assemblies Chem. Soc. Rev. 2016 45 24 39 10.1039/C5CS00157A 26497225 [43] Carmona F Poli M Bertuzzi M Gianoncelli A Gangemi F Arosio P Study of ferritin self-assembly and heteropolymer formation by the use of fluorescence resonance energy transfer (FRET) technology Biochim. Biophys. Acta. Gen. Subj. 2017 1861 522 532 10.1016/j.bbagen.2016.12.011 27993659 [44] Wege C Koch C From stars to stripes: RNA-directed shaping of plant viral protein templates-structural synthetic virology for smart biohybrid nanostructures Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2020 12 e1591 10.1002/wnan.1591 31631528 [45] Fiedler J D Fishman M R Brown S D Lau J Finn M G Multifunctional enzyme packaging and catalysis in the Qβ protein nanoparticle Biomacromolecules 2011 19 3945 3957 10.1021/acs.biomac.8b00885 [46] Wang J C Liu Y C Chen Y M Zhang T Wang A P Wei Q Liu D M Wang F Y Zhang G P Capsid assembly is regulated by amino acid residues asparagine 47 and 48 in the VP2 protein of porcine parvovirus Vet. Microbiol. 2021 253 108974 10.1016/j.vetmic.2020.108974 33433338 [47] Harrison P M Arosio P The ferritins: Molecular properties, iron storage function and cellular regulation Biochim. Biophys. Acta Bioenerg. 1996 1275 161 203 10.1016/0005-2728(96)00022-9 [48] Arosio P Elia L Poli M Ferritin, cellular iron storage and regulation IUBMB Life 2017 69 414 422 10.1002/iub.1621 28349628 [49] Uchida M Kang S Reichhardt C Harlen K Douglas T The ferritin superfamily: Supramolecular templates for materials synthesis Biochim. Biophys. Acta. Gen. Subj. 2010 1800 834 845 10.1016/j.bbagen.2009.12.005 [50] Harrison P M Fischbach F A Hoy T G Haggis G H Ferric oxyhydroxide core of ferritin Nature 1967 216 1188 1190 10.1038/2161188a0 6076063 [51] Bertini I Lalli D Mangani S Pozzi C Rosa C Theil E C Turano P Structural insights into the ferroxidase site of ferritins from higher eukaryotes J. Am. Chem. Soc. 2012 134 6169 6176 10.1021/ja210084n 22424302 [52] Arosio P Ingrassia R Cavadini P Ferritins: A family of molecules for iron storage, antioxidation and more Biochim. Biophys. Acta. Gen. Subj. 2009 1790 589 599 10.1016/j.bbagen.2008.09.004 [53] Torti F M Torti S V Regulation of ferritin genes and protein Blood 2002 99 3505 3516 10.1182/blood.V99.10.3505 11986201 [54] Damiani V Falvo E Fracasso G Federici L Pitea M De Laurenzi V Sala G Ceci P Therapeutic efficacy of the novel stimuli-sensitive nano-ferritins containing doxorubicin in a head and neck cancer model Int. J. Mol. Sci. 2017 18 1555 10.3390/ijms18071555 28718812 [55] Fracasso G Falvo E Colotti G Fazi F Ingegnere T Amalfitano A Doglietto G B Alfieri S Boffi A Morea V Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness J. Controlled Release 2016 239 10 18 10.1016/j.jconrel.2016.08.010 [56] Falvo E Tremante E Arcovito A Papi M Elad N Boffi A Morea V Conti G Toffoli G Fracasso G Improved doxorubicin encapsulation and pharmacokinetics of ferritin-fusion protein nanocarriers bearing proline, serine, and alanine elements Biomacromolecules 2016 17 514 522 10.1021/acs.biomac.5b01446 26686226 [57] Huang C Chu C C Wang X Y Lin H R Wang J Q Zeng Y Zhu W Z Wang Y X J Liu G Ultra-high loading of sinoporphyrin sodium in ferritin for single-wave motivated photothermal and photodynamic co-therapy Biomater. Sci. 2017 5 1512 1516 10.1039/C7BM00302A 28617486 [58] Pandolfi L Bellini M Vanna R Morasso C Zago A Carcano S Avvakumova S Bertolini J A Rizzuto M A Colombo M H-ferritin enriches the curcumin uptake and improves the therapeutic efficacy in triple negative breast cancer cells Biomacromolecules 2017 18 3318 3330 10.1021/acs.biomac.7b00974 28886247 [59] Falvo E Malagrinò F Arcovito A Fazi F Colotti G Tremante E Di Micco P Braca A Opri R Giuffrè A The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity J. Controlled Release 2018 275 177 185 10.1016/j.jconrel.2018.02.025 [60] Ryser H Caulfield J B Aub J C Studies on protein uptake by isolated tumor cells. I. Electron microscopic evidence of ferritin uptake by ehrlich ascites tumor cells J. Cell Biol. 1962 14 255 268 10.1083/jcb.14.2.255 14495656 [61] Caulfield J B Studies on ferritin uptake by isolated tumor cells Lab. Invest. 1963 12 1018 1025 14084842 [62] Easty G C Yarnell M M Andrews R D The uptake of proteins by normal and tumour cells in vitro Br. J. Cancer 1965 18 354 367 10.1038/bjc.1964.41 [63] Li L Fang C J Ryan J C Niemi E C Lebrón J A Björkman P J Arase H Torti F M Torti S V Nakamura M C Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 Proc. Natl. Acad. Sci. USA 2010 107 3505 3510 10.1073/pnas.0913192107 20133674 [64] Kawabata H Transferrin and transferrin receptors update Free Radic. Biol. Med. 2019 133 46 54 10.1016/j.freeradbiomed.2018.06.037 29969719 [65] Fan K L Cao C Q Pan Y X Lu D Yang D L Feng J Song L N Liang M M Yan X Y Magnetoferritin nanoparticles for targeting and visualizing tumour tissues Nat. Nanotechnol. 2012 7 765 10.1038/nnano.2012.204 [66] Wang B Tang M Yuan Z Li Z Hu B Bai X Chu J Xu X Zhang X Targeted delivery of a sting agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy Bioact. Mater. 2022 16 232 248 10.1016/j.bioactmat.2022.02.026 35386310 [67] Lajoie J M Shusta E V Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier Annu. Rev. Pharmacol. Toxicol. 2015 55 613 631 10.1146/annurev-pharmtox-010814-124852 25340933 [68] Fan K L Jia X H Zhou M Wang K Conde J He J Y Tian J Yan X Y Ferritin nanocarrier traverses the blood brain barrier and kills glioma ACS Nano 2018 12 4105 4115 10.1021/acsnano.7b06969 29608290 [69] Richter K Haslbeck M Buchner J The heat shock response: Life on the verge of death Mol. Cell. 2010 40 253 266 10.1016/j.molcel.2010.10.006 20965420 [70] Guo M Liu J H Ma X Luo D X Gong Z H Lu M H The plant heat stress transcription factors (HSFs): Structure, regulation, and function in response to abiotic stresses Front. Plant Sci. 2016 7 114 10.3389/fpls.2016.00114 26904076 [71] Shende P Bhandarkar S Prabhakar B Heat shock proteins and their protective roles in stem cell biology Stem Cell Rev. Rep. 2019 15 637 651 10.1007/s12015-019-09903-5 31254166 [72] Smith D F Whitesell L Katsanis E Molecular chaperones: Biology and prospects for pharmacological intervention Pharmacol. Rev. 1998 50 493 514 9860803 [73] Tsukahara F Yoshioka T Muraki T Molecular and functional characterization of HSC54, a novel variant of human heat-shock cognate protein 70 Mol. Pharmacol. 2000 58 1257 1263 10.1124/mol.58.6.1257 11093761 [74] Stromer T Fischer E Richter K Haslbeck M Buchner J Analysis of the regulation of the molecular chaperone Hsp26 by temperature-induced dissociation: The N-terminal domain is important for oligomer assembly and the binding of unfolding proteins J. Biol. Chem. 2004 279 11222 11228 10.1074/jbc.M310149200 14722093 [75] Kim K K Kim R Kim S H Crystal structure of a small heat-shock protein Nature 1998 394 595 599 10.1038/29106 9707123 [76] Kim R Kim K K Yokota H Kim S H Small heat shock protein of Methanococcus jannaschii , a hyperthermophile Proc. Natl. Acad. Sci. USA 1998 95 9129 9133 10.1073/pnas.95.16.9129 9689045 [77] Kim K K Yokota H Santoso S Lerner D Kim R Kim S H Purification, crystallization, and preliminary X-ray crystallographic data analysis of small heat shock protein homolog from Methanococcus jannaschii , a hyperthermophile J. Struct. Biol. 1998 121 76 80 10.1006/jsbi.1998.3969 9573624 [78] Flenniken M L Willits D A Brumfield S Young M J Douglas T The small heat shock protein cage from Methanococcus jannaschii is a versatile nanoscale platform for genetic and chemical modification Nano Lett. 2003 3 1573 1576 10.1021/nl034786l [79] Bova M P Ding L L Horwitz J Fung B K K Subunit exchange of αA-crystallin J. Biol. Chem. 1997 272 29511 29517 10.1074/jbc.272.47.29511 9368012 [80] Choi S H Kwon I C Hwang K Y Kim I S Ahn H J Small heat shock protein as a multifunctional scaffold: Integrated tumor targeting and caspase imaging within a single cage Biomacromolecules 2011 12 3099 3106 10.1021/bm200743g 21728293 [81] Flenniken M L Liepold L O Crowley B E Willits D A Young M J Douglas T Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture Chem. Commun. 2005 447 449 [82] Kawano T Murata M Kang J H Piao J S Narahara S Hyodo F Hamano N Guo J Oguri S Ohuchida K Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent Biomaterials 2018 152 37 46 10.1016/j.biomaterials.2017.10.029 29107217 [83] Suprenant K A Vault ribonucleoprotein particles: Sarcophagi, gondolas, or safety deposit boxes Biochemistry 2002 41 14447 14454 10.1021/bi026747e 12463742 [84] Van Zon A Mossink M H Scheper R J Sonneveld P Wiemer E A C The vault complex Cell. Mol. Life Sci. 2003 60 1828 1837 10.1007/s00018-003-3030-y 14523546 [85] Kedersha N L Rome L H Isolation and characterization of a novel ribonucleoprotein particle: Large structures contain a single species of small RNA J. Cell Biol. 1986 103 699 709 10.1083/jcb.103.3.699 2943744 [86] Ding K Zhang X Mrazek J Kickhoefer V A Lai M Ng H L Yang O O Rome L H Zhou Z H Solution structures of engineered vault particles Structure 2018 26 619 626 10.1016/j.str.2018.02.014 29551289 [87] Stephen A G Raval-Fernandes S Huynh T Torres M Kickhoefer V A Rome L H Assembly of vault-like particles in insect cells expressing only the major vault protein J. Biol. Chem 2001 276 23217 23220 10.1074/jbc.C100226200 11349122 [88] Mikyas Y Makabi M Raval-Fernandes S Harrington L Kickhoefer V A Rome L H Stewart P L Cryoelectron microscopy imaging of recombinant and tissue derived vaults: Localization of the MVP N termini and VPARP J. Mol. Biol. 2004 344 91 105 10.1016/j.jmb.2004.09.021 15504404 [89] Kickhoefer V A Liu Y E Kong L B Snow B E Stewart P L Harrington L Rome L H The telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle J. Cell Biol. 2001 152 157 164 10.1083/jcb.152.1.157 11149928 [90] Frascotti G Galbiati E Mazzucchelli M Pozzi M Salvioni L Vertemara J Tortora P The vault nanoparticle: A gigantic ribonucleoprotein assembly involved in diverse physiological and pathological phenomena and an ideal nanovector for drug delivery and therapy Cancers 2021 13 707 10.3390/cancers13040707 33572350 [91] Voth B L Pelargos P E Barnette N E Bhatt N S Chen C H J Lagman C Chung L K Nguyen T Sheppard J P Romiyo P Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma J. Neurooncol. 2020 147 599 605 10.1007/s11060-020-03479-8 32274629 [92] Goldsmith L E Yu M Rome L H Monbouquette H G Vault nanocapsule dissociation into halves triggered at low pH Biochemistry 2007 46 2865 2875 10.1021/bi0606243 17302392 [93] Esfandiary R Kickhoefer V A Rome L H Joshi S B Middaugh C R Structural stability of vault particles J. Pharm. Sci. 2009 98 1376 1386 10.1002/jps.21508 18683860 [94] Barth H Ulsenheimer A Pape G R Diepolder H M Hoffmann M Neumann-Haefelin C Thimme R Henneke P Klein R Paranhos-Baccala G Uptake and presentation of hepatitis C virus-like particles by human dendritic cells Blood 2005 105 3605 3614 10.1182/blood-2004-05-1952 15657184 [95] Crisci E Bárcena J Montoya M Virus-like particles: The new frontier of vaccines for animal viral infections Vet. Immunol. Immunopathol. 2012 148 211 225 10.1016/j.vetimm.2012.04.026 22705417 [96] Lin T W Chen Z G Usha R Stauffacher C V Dai J B Schmidt T Johnson J E The refined crystal structure of cowpea mosaic virus at 2. 8 Å resolution Virology 1999 265 20 34 10.1006/viro.1999.0038 10603314 [97] Speir J A Bothner B Qu C X Willits D A Young M J Johnson J E Enhanced local symmetry interactions globally stabilize a mutant virus capsid that maintains infectivity and capsid dynamics J. Virol. 2006 80 3582 3591 10.1128/JVI.80.7.3582-3591.2006 16537626 [98] Cui Z C Gorzelnik K V Chang J Y Langlais C Jakana J Young R Zhang J J Structures of Qβ virions, virus-like particles, and the Qβ-murA complex reveal internal coat proteins and the mechanism of host lysis Proc. Natl. Acad. Sci. USA 2017 114 11697 11702 10.1073/pnas.1707102114 29078304 [99] Franzen S Lommel S A Targeting cancer with ‘smart bombs’: Equipping plant virus nanoparticles for a ‘seek and destroy’ mission Nanomedicine 2009 4 575 588 10.2217/nnm.09.23 19572822 [100] Ren Y P Wong S M Lim L Y Application of plant viruses as nano drug delivery systems Pharm. Res. 2010 27 2509 2513 10.1007/s11095-010-0251-2 20811934 [101] Chung Y H Cai H Steinmetz N F Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications Adv. Drug Deliv. Rev. 2020 156 214 235 10.1016/j.addr.2020.06.024 32603813 [102] Liu J L Dixit A B Robertson K L Qiao E Black L W Viral nanoparticle-encapsidated enzyme and restructured DNA for cell delivery and gene expression Proc. Natl. Acad. Sci. USA 2014 111 13319 13324 10.1073/pnas.1321940111 25161284 [103] Lam P Steinmetz N F Delivery of siRNA therapeutics using cowpea chlorotic mottle virus-like particles Biomater. Sci. 2019 7 3138 3142 10.1039/C9BM00785G 31257379 [104] Frietze K M Peabody D S Chackerian B Engineering virus-like particles as vaccine platforms Curr. Opin. Virol. 2016 18 44 49 10.1016/j.coviro.2016.03.001 27039982 [105] Balke I Zeltins A Use of plant viruses and virus-like particles for the creation of novel vaccines Adv. Drug Deliv. Rev 2019 145 119 129 10.1016/j.addr.2018.08.007 30172923 [106] Neek M Kim T I Wang S W Protein-based nanoparticles in cancer vaccine development Nanomed. Nanotechnol. Biol. Med. 2019 15 164 174 10.1016/j.nano.2018.09.004 [107] Zepeda-Cervantes J Ramírez-Jarquín J O Vaca L Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): Toward better engineering of VLPs Front. Immunol. 2020 11 1100 10.3389/fimmu.2020.01100 32582186 [108] Shukla S Wang C Beiss V Cai H Washington T II Murray A A Gong X J Zhao Z C Masarapu H Zlotnick A The unique potency of cowpea mosaic virus (CPMV) in situ cancer vaccine Biomater. Sci. 2020 8 5489 5503 10.1039/D0BM01219J 32914796 [109] Linder M B Szilvay G R Nakari-Setälä T Penttilä M E Hydrophobins: The protein-amphiphiles of filamentous fungi FEMS Microbiol. Rev. 2005 29 877 896 10.1016/j.femsre.2005.01.004 16219510 [110] Wessels J G H Hydrophobins: Proteins that change the nature of the fungal surface Adv. Microb. Physiol. 1996 38 1 45 10.1016/S0065-2911(08)60154-X [111] Wösten H A B Scholtmeijer K Applications of hydrophobins: Current state and perspectives Appl. Microbiol. Biotechnol 2015 99 1587 1597 10.1007/s00253-014-6319-x 25564034 [112] Wessels J G H Developmental regulation of fungal cell wall formation Annu. Rev. Phytopathol. 1994 32 413 437 10.1146/annurev.py.32.090194.002213 [113] Kwan A H Winefield R D Sunde M Matthews J M Haverkamp R G Templeton M D Mackay J P Structural basis for rodlet assembly in fungal hydrophobins Proc. Natl. Acad. Sci. U.S.A. 2006 103 3621 3626 10.1073/pnas.0505704103 16537446 [114] Kallio J M Linder M B Rouvinen J Crystal structures of hydrophobin HFBII in the presence of detergent implicate the formation of fibrils and monolayer films J. Biol. Chem. 2007 282 28733 28739 10.1074/jbc.M704238200 17636262 [115] Fang G H Tang B Liu Z T Gou J X Zhang Y Xu H Tang X Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: In vitro characteristics and in vivo performance Eur. J. Pharm. Sci. 2014 60 1 9 10.1016/j.ejps.2014.04.016 24815943 [116] Maiolo D Pigliacelli C Moreno P S Violatto M B Talamini L Tirotta I Piccirillo R Zucchetti M Morosi L Frapolli R Bioreducible hydrophobin-stabilized supraparticles for selective intracellular release ACS Nano 2017 11 9413 9423 10.1021/acsnano.7b04979 28806871 [117] Holt C Carver J A Ecroyd H Thorn D C Invited review : Caseins and the casein micelle: Their biological functions, structures, and behavior in foods J. Dairy Sci. 2013 96 6127 6146 10.3168/jds.2013-6831 23958008 [118] Artym J Zimecki M Milk-derived proteins and peptides in clinical trials Postepy Hig. Med. Dosw. 2013 67 800 816 10.5604/17322693.1061635 [119] Elzoghby A O Abo El-Fotoh W S Elgindy N A Casein-based formulations as promising controlled release drug delivery systems J. Controlled Release 2011 153 206 216 10.1016/j.jconrel.2011.02.010 [120] Horne D S Casein structure, self-assembly and gelation Curr. Opin. Colloid Interface Sci. 2002 7 456 461 10.1016/S1359-0294(02)00082-1 [121] Huppertz T De Kruif C G Structure and stability of nanogel particles prepared by internal cross-linking of casein micelles Int. Dairy J. 2008 18 556 565 10.1016/j.idairyj.2007.10.009 [122] Kumosinski T F Brown E M Farrell H M Jr. Three-dimensional molecular modeling of bovine caseins: An energy-minimized β -casein structure J. Dairy Sci. 1993 76 931 945 10.3168/jds.S0022-0302(93)77420-2 8486844 [123] Tai M S Kegeles G A micelle model for the sedimentation behavior of bovine β-casein Biophys. Chem. 1984 20 81 87 10.1016/0301-4622(84)80007-1 6487747 [124] Portnaya I Ben-Shoshan E Cogan U Khalfin R Fass D Ramon O Danino D Self-assembly of bovine β-casein below the isoelectric pH J. Agric. Food Chem. 2008 56 2192 2198 10.1021/jf072630r 18303844 [125] Javor G T Sood S M Chang P Slattery C W Interactions of triply phosphorylated human β-casein: Fluorescence spectroscopy and light-scattering studies of conformation and self-association Arch. Biochem. Biophys. 1991 289 39 46 10.1016/0003-9861(91)90439-P 1898063 [126] Livney Y D Milk proteins as vehicles for bioactives Curr. Opin. Colloid Interface Sci. 2010 15 73 83 10.1016/j.cocis.2009.11.002 [127] Trejo R Dokland T Jurat-Fuentes J Harte F Cryo-transmission electron tomography of native casein micelles from bovine milk J. Dairy Sci. 2011 94 5770 5775 10.3168/jds.2011-4368 22118067 [128] Pasquali-Ronchetti I Baccarani-Contri M Elastic fiber during development and aging Microsc. Res. Tech. 1997 38 428 435 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L 9297692 [129] Martyn C Greenwald S A hypothesis about a mechanism for the programming of blood pressure and vascular disease in early life Clin. Exp. Pharmacol. Physiol. 2001 28 948 951 10.1046/j.1440-1681.2001.03555.x 11703403 [130] Faury G Function-structure relationship of elastic arteries in evolution: From microfibrils to elastin and elastic fibres Pathol. Biol. 2001 49 310 325 10.1016/S0369-8114(01)00147-X 11428167 [131] Tatham A S Shewry P R Elastomeric proteins: Biological roles, structures and mechanisms Trends Biochem. Sci. 2000 25 567 571 10.1016/S0968-0004(00)01670-4 11084370 [132] Yeboah A Cohen R I Rabolli C Yarmush M L Berthiaume F Elastin-like polypeptides: A strategic fusion partner for biologics Biotechnol. Bioeng. 2016 113 1617 1627 10.1002/bit.25998 27111242 [133] Straley K S Heilshorn S C Independent tuning of multiple biomaterial properties using protein engineering Soft Matter 2009 5 114 124 10.1039/B808504H [134] Catherine C Oh S J Lee K H Min S E Won J I Yun H Kim D M Engineering thermal properties of elastin-like polypeptides by incorporation of unnatural amino acids in a cell-free protein synthesis system Biotechnol. Bioprocess Eng 2015 20 417 422 10.1007/s12257-015-0190-1 [135] Bataille L Dieryck W Hocquellet A Cabanne C Bathany K Lecommandoux S Garbay B Garanger E Recombinant production and purification of short hydrophobic elastin-like polypeptides with low transition temperatures Protein Exp. Purif 2016 121 81 87 10.1016/j.pep.2016.01.010 [136] Urry D W Trapane T L Prasad K U Phase-structure transitions of the elastin polypentapeptide-water system within the framework of composition-temperature studies Biopolymers 1985 24 2345 2356 10.1002/bip.360241212 4092092 [137] Urry D W Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers J. Phys. Chem. B 1997 101 11007 11028 10.1021/jp972167t [138] Dhandhukia J P Shi P Peddi S Li Z Aluri S Ju Y P Brill D Wang W Janib S M Lin Y A Bifunctional elastin-like polypeptide nanoparticles bind rapamycin and integrins and suppress tumor growth in vivo Bioconjug. Chem 2017 28 2715 2728 10.1021/acs.bioconjchem.7b00469 28937754 [139] Utterström J Naeimipour S Selegård R Aili D Coiled coil-based therapeutics and drug delivery systems Adv. Drug Deliv. Rev. 2021 170 26 43 10.1016/j.addr.2020.12.012 33378707 [140] Liu J Zheng Q Deng Y Q Cheng C S Kallenbach N R Lu M A seven-helix coiled coil Proc. Natl. Acad. Sci. USA 2006 103 15457 15462 10.1073/pnas.0604871103 17030805 [141] Lupas A N Bassler J Dunin-Horkawicz S Parry D A D Squire J M The structure and topology of α-helical coiled coils Fibrous Proteins: Structures and Mechanisms 2017 Cham Springer 95 129 [142] Apostolovic B Klok H A pH-sensitivity of the E3/K3 heterodimeric coiled coil Biomacromolecules 2001 9 3173 3180 10.1021/bm800746e [143] Fletcher J M Harniman R L Barnes F R H Boyle A L Collins A Mantell J Sharp T H Antognozzi M Booth P J Linden N Self-assembling cages from coiled-coil peptide modules Science 2013 340 595 599 10.1126/science.1233936 23579496 [144] Ljubetič A Lapenta F Gradišar H Drobnak I Aupič J Strmšek Ž Lainšček D Hafner-Bratkovič I Majerle A Krivec N Design of coiled-coil protein-origami cages that self-assemble in vitro and in vivo Nat. Biotechnol 2017 35 1094 1101 10.1038/nbt.3994 29035374 [145] Raman S Machaidze G Lustig A Aebi U Burkhard P Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles Nanomed. Nanotechnol. Biol. Med. 2006 2 95 102 10.1016/j.nano.2006.04.007 [146] Beck K Gambee J E Kamawal A Bächinger H P A single amino acid can switch the oligomerization state of the α-helical coiled-coil domain of cartilage matrix protein EMBO J. 1997 16 3767 3777 10.1093/emboj/16.13.3767 9233786 [147] Dames S A Kammerer R A Wiltscheck R Engel J Alexandrescu A T NMR structure of a parallel homotrimeric coiled coil Nat. Struct. Biol. 1991 5 687 691 10.1038/90444 [148] Klatt A R Becker A K A Neacsu C D Paulsson M Wagener R The matrilins: Modulators of extracellular matrix assembly Int. J. Biochem. Cell Biol. 2011 43 320 330 10.1016/j.biocel.2010.12.010 21163365 [149] Wiltscheck R Dames S A Alexandrescu A T Kammerer R A Schulthess T Blommers M J J Engel J Heteronuclear NMR assignments and secondary structure of the coiled coil trimerization domain from cartilage matrix protein in oxidized and reduced forms Protein Sci. 1997 6 1734 1745 10.1002/pro.5560060814 9260286 [150] Eriksson M Hassan S Larsson R Linder S Ramqvist T Lövborg H Vikinge T Figgemeier E Müller J Stetefeld J Utilization of a right-handed coiled-coil protein from archaebacterium staphylothermus marinus as a carrier for cisplatin Anticancer Res. 2009 29 11 18 19331128 [151] Fan J Q Fan Y Wei Z J Li Y J Li X D Wang L Wang H Transformable peptide nanoparticles inhibit the migration of N-cadherin overexpressed cancer cells Chin. Chem. Lett 2020 31 1787 1791 10.1016/j.cclet.2020.03.065 [152] Zhou X Y Su X K Zhou C C Preparation of diblock amphiphilic polypeptide nanoparticles for medical applications Eur. Polym. J. 2011 100 132 136 10.1016/j.eurpolymj.2018.01.025 [153] Choi H Liu T Nath K Zhou R Chen I W Peptide nanoparticle with pH-sensing cargo solubility enhances cancer drug efficiency Nano Today 2017 13 15 22 10.1016/j.nantod.2017.02.008 [154] Sigg S J Postupalenko V Duskey J T Palivan C G Meier W Stimuli-responsive codelivery of oligonucleotides and drugs by self-assembled peptide nanoparticles Biomacromolecules 2016 17 935 945 10.1021/acs.biomac.5b01614 26871486 [155] Gong Z Y Lao J Gao F Lin W P Yu T Zhou B L Dong J H Liu H Bai J K pH-triggered geometrical shape switching of a cationic peptide nanoparticle for cellular uptake and drug delivery Colloids Surf. B Biointerfaces 2020 188 110811 10.1016/j.colsurfb.2020.110811 31982793 [156] Gong Z Y Liu X Y Zhou B L Wang G H Guan X W Xu Y Zhang J J Hong Z X Cao J J Sun X R Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy Colloids Surf. B Biointerfaces 2021 202 111673 10.1016/j.colsurfb.2021.111673 33714186 [157] Cabral H Matsumoto Y Mizuno K Chen Q Murakami M Kimura M Terada Y Kano M R Miyazono K Uesaka M Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol 2011 6 815 823 10.1038/nnano.2011.166 22020122 [158] Raj S Khurana S Choudhari R Kesari K K Kamal M A Garg N Ruokolainen J Das B C Kumar D Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy Semin. Cancer Biol. 2021 69 166 177 10.1016/j.semcancer.2019.11.002 31715247 [159] Chithrani B D Ghazani A A Chan W C W Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett. 2006 6 662 668 10.1021/nl052396o 16608261 [160] Hoshyar N Gray S Han H B Bao G The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction Nanomedicine 2016 11 673 692 10.2217/nnm.16.5 27003448 [161] Li H L Li J M He X Y Zhang B Liu C X Li Q F Zhu Y Huang W L Zhang W Qian H Histology and antitumor activity study of PTX-loaded micelle, a fluorescent drug delivery system prepared by PEG-TPP Chin. Chem. Lett. 2019 30 1083 1088 10.1016/j.cclet.2019.01.003 [162] Huang K Z Gao M Y Fan L Lai Y Y Fan H W Hua Z Z IR820 covalently linked with self-assembled polypeptide for photothermal therapy applications in cancer Biomater. Sci. 2011 6 2925 2931 10.1039/C8BM00399H [163] Huang X Yin Y L Wu M Zan W Yang Q LyP-1 peptide-functionalized gold nanoprisms for SERRS imaging and tumor growth suppressing by PTT induced-hyperthermia Chin. Chem. Lett. 2019 30 1335 1340 10.1016/j.cclet.2019.02.019 [164] Wen S F Zhang K Li Y Fan J Q Chen Z M Zhang J P Wang H Wang L A self-assembling peptide targeting VEGF receptors to inhibit angiogenesis Chin. Chem. Lett. 2020 31 3153 3157 10.1016/j.cclet.2020.03.077 [165] Peng J F Wang R R Sun W R Huang M H Wang R Li Y J Wang P Y Sun G B Xie S Y Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer Biomater. Sci 2021 9 6528 6541 10.1039/D1BM01124C 34582541 [166] Xiao Y J Zhang Q Wang Y Y Wang B Sun F N Han Z Y Feng Y Q Yang H T Meng S X Wang Z F Dual-functional protein for one-step production of a soluble and targeted fluorescent dye Theranostics 2018 8 3111 3125 10.7150/thno.24613 29896306 [167] Fan R R Mei L Gao X Wang Y L Xiang M L Zheng Y Tong A P Zhang X N Han B Zhou L X Self-assembled bifunctional peptide as effective drug delivery vector with powerful antitumor activity Adv. Sci. 2017 4 1600285 10.1002/advs.201600285 [168] Pastorino F Brignole C Marimpietri D Cilli M Gambini C Ribatti D Longhi R Allen T M Corti A Ponzoni M Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy Cancer Res. 2003 63 7400 7409 14612539 [169] Garde S V Forté A J Ge M Lepekhin E A Panchal C J Rabbani S A Wu J J Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects Anti-Cancer Drugs 2007 18 1189 1200 10.1097/CAD.0b013e3282a213ce 17893520 [170] Negussie A H Miller J L Reddy G Drake S K Wood B J Dreher M R Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome J. Controlled Release 2010 143 265 273 10.1016/j.jconrel.2009.12.031 [171] Sudimack J Lee R J Targeted drug delivery via the folate receptor Adv. Drug Deliv. Rev. 2000 41 147 162 10.1016/S0169-409X(99)00062-9 10699311 [172] Lu Y J Low P S Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv. Drug Deliv. Rev. 2012 64 342 352 10.1016/j.addr.2012.09.020 [173] Thong Q X Biabanikhankahdani R Ho K L Alitheen N B Tan W S Thermally-responsive virus-like particle for targeted delivery of cancer drug Sci. Rep. 2019 9 3945 10.1038/s41598-019-40388-x 30850643 [174] Chen H M Qin Z N Zhao J M He Y Ren E Zhu Y Liu G Mao C B Zheng L Cartilage-targeting and dual MMP-13/pH responsive theranostic nanoprobes for osteoarthritis imaging and precision therapy Biomaterials 2019 225 119520 10.1016/j.biomaterials.2019.119520 31586865 [175] Högemann-Savellano D Bos E Blondet C Sato F Abe T Josephson L Weissleder R Gaudet J Sgroi D Peters P J The transferrin receptor: A potential molecular imaging marker for human cancer Neoplasia 2003 5 495 506 10.1016/S1476-5586(03)80034-9 14965443 [176] Mendes-Jorge L Ramos D Valença A López-Luppo M Pires V M R Catita J Nacher V Navarro M Carretero A Rodriguez-Baeza A L-ferritin binding to scara5: A new iron traffic pathway potentially implicated in retinopathy PLoS One 2014 9 e106974 10.1371/journal.pone.0106974 25259650 [177] Dong Y X Ma Y M Li X Wang F Zhang Y ERK-peptide-inhibitor-modified ferritin enhanced the therapeutic effects of paclitaxel in cancer cells and spheroids Mol. Pharm 2021 18 3365 3377 10.1021/acs.molpharmaceut.1c00303 34370483 [178] Owens D E III Peppas N A Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm 2006 307 93 102 10.1016/j.ijpharm.2005.10.010 16303268 [179] Singh A Xu J Mattheolabakis G Amiji M EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model Nanomed. Nanotechnol. Biol. Med. 2016 12 589 600 10.1016/j.nano.2015.11.010 [180] Hu H Steinmetz N F Doxorubicin-loaded physalis mottle virus particles function as a pH-responsive prodrug enabling cancer therapy Biotechnol. J. 2020 15 2000077 10.1002/biot.202000077 [181] Wang C Y Zhang C Li Z L Yin S Wang Q Guo F X Zhang Y Yu R Liu Y D Su Z G Extending half life of H-ferritin nanoparticle by fusing albumin binding domain for doxorubicin encapsulation Biomacromolecules 2018 19 773 781 10.1021/acs.biomac.7b01545 29328653 [182] Jin P P Sha R Zhang Y J Liu L Bian Y P Qian J Qian J Y Lin J Ishimwe N Hu Y Blood circulation-prolonging peptides for engineered nanoparticles identified via phage display Nano Lett. 2019 19 1467 1478 10.1021/acs.nanolett.8b04007 30730145 [183] Chen Y X Wei C X Lyu Y Q Chen H Z Jiang G Gao X L Biomimetic drug-delivery systems for the management of brain diseases Biomater. Sci. 2020 8 1073 1088 10.1039/C9BM01395D 31728485 [184] Zhang H Y Van Os W L Tian X B Zu G Y Ribovski L Bron R Bussmann J Kros A Liu Y Zuhorn I S Development of curcumin-loaded zein nanoparticles for transport across the blood-brain barrier and inhibition of glioblastoma cell growth Biomater. Sci. 2021 9 7092 7103 10.1039/D0BM01536A 33538729 [185] Wen L J Peng Y Wang K Huang Z H He S Y Xiong R W Wu L P Zhang F T Hu F Q Regulation of pathological BBB restoration via nanostructured ROS-responsive glycolipid-like copolymer entrapping siVEGF for glioblastoma targeted therapeutics Nano Res. 2022 15 1455 1465 10.1007/s12274-021-3686-3 [186] Li Y R Zhang X J Qi Z F Guo X L Liu X P Shi W J Liu Y Du L B The enhanced protective effects of salvianic acid A: A functionalized nanoparticles against ischemic stroke through increasing the permeability of the blood-brain barrier Nano Res 2020 13 2791 2802 10.1007/s12274-020-2930-6 [187] Pang H H Huang C Y Chou Y W Lin C J Zhou Z L Shiue Y L Wei K C Yang H W Bioengineering fluorescent virus-like particle/RNAi nanocomplexes act synergistically with temozolomide to eradicate brain tumors Nanoscale 2019 11 8102 8109 10.1039/C9NR01247H 30982841 [188] Liu W Lin Q Fu Y Huang S Q Guo C Q Li L Wang L L Zhang Z R Zhang L Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment J. Controlled Release 2020 323 191 202 10.1016/j.jconrel.2019.12.010 [189] Huang C W Chuang C P Chen Y J Wang H Y Lin J J Huang C Y Wei K C Huang F T Integrin α 2 β 1 -targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy J. Nanobiotechnol. 2021 19 180 10.1186/s12951-021-00925-1 [190] Zhao S Duan H X Yang Y L Yan X Y Fan K L Fenozyme protects the integrity of the blood-brain barrier against experimental cerebral malaria Nano Lett. 2019 19 8887 8895 10.1021/acs.nanolett.9b03774 31671939 [191] Chen Z Y Liao T Wan L H Kuang Y Liu C Duan J L Xu X Y Xu Z Q Jiang B B Li C Dual-stimuli responsive near-infrared emissive carbon dots/hollow mesoporous silica-based integrated theranostics platform for real-time visualized drug delivery Nano Res. 2021 14 4264 4273 10.1007/s12274-021-3624-4 [192] Li H P Zhou Z W Zhang F R Guo Y X Yang X Jiang H L Tan F Oupicky D Sun M J A networked swellable dextrin nanogels loading Bcl2 siRNA for melanoma tumor therapy Nano Res. 2018 11 4627 4642 10.1007/s12274-018-2044-6 [193] Yao H C Zhao W W Zhang S G Guo X F Li Y Du B Dual-functional carbon dot-labeled heavy-chain ferritin for self-targeting bio-imaging and chemo-photodynamic therapy J. Mater. Chem. B 2018 6 3107 3115 10.1039/C8TB00118A 32254345 [194] Niikura K Sugimura N Musashi Y Mikuni S Matsuo Y Kobayashi S Nagakawa K Takahara S Takeuchi C Sawa H Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells Mol. BioSyst. 2013 9 501 507 10.1039/c2mb25420d 23361582 [195] Aljabali A A A Shukla S Lomonossoff G P Steinmetz N F Evans D J CPMV-DOX delivers Mol. Pharm. 2013 10 3 10 10.1021/mp3002057 22827473 [196] Nguyen B Tolia N H Protein-based antigen presentation platforms for nanoparticle vaccines npj Vaccines 2021 6 70 10.1038/s41541-021-00330-7 33986287 [197] Gobeil, P.; Pillet, S.; Boulay, I.; Séguin, A.; Makarkov, A.; Heizer, G.; Bhutada, K.; Mahmood, A.; Charland, N.; Trépanier, S. et al. Phase 2 randomized trial of an AS03 adjuvanted plant-based virus-like particle vaccine for Covid-19 in healthy adults, older adults and adults with comorbidities. medRxiv , in press, 10.1101/2021.05.14.21257248. [198] Ward B J Séguin A Couillard J Trépanier S Landry N Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age Vaccine 2021 39 1528 1533 10.1016/j.vaccine.2021.01.004 33581920 [199] Chichester J A Green B J Jones R M Shoji Y Miura K Long C A Lee C K Ockenhouse C F Morin M J Streatfield S J Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A phase 1 dose-escalation study in healthy adults Vaccine 2018 36 5865 5871 10.1016/j.vaccine.2018.08.033 30126674 [200] Pillet S Aubin É Trépanier S Poulin J F Yassine-Diab B Meulen J T Ward B J Landry N Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a phase 2 clinical trial npj Vaccines 2018 3 3 10.1038/s41541-017-0043-3 29387473 [201] Chichester J A Jones R M Green B J Stow M Miao F D Moonsammy G Streatfield S J Yusibov V Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/indonesia/05/2005 (H5N1) influenza virus: A phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults Viruses 2012 4 3227 3244 10.3390/v4113227 23202523 [202] Cummings J F Guerrero M L Moon J E Waterman P Nielsen R K Jefferson S Gross F L Hancock K Katz J M Yusibov V Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza a (H1N1)pdm09 virus: A phase 1 dose-escalation study in healthy adults Vaccine 2014 32 2251 2259 10.1016/j.vaccine.2013.10.017 24126211 [203] Ortega-Rivera O A Shin M D Chen A Beiss V Moreno-Gonzalez M A Lopez-Ramirez M A Reynoso M Wang H Hurst B L Wang J Trivalent subunit vaccine candidates for COVID-19 and their delivery devices J. Am. Chem. Soc. 2021 143 14748 14765 10.1021/jacs.1c06600 34490778 [204] Christiansen D Earnest-Silveira L Chua B Meuleman P Boo I Grubor-Bauk B Jackson D C Keck Z Y Foung S K H Drummer H E Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine Sci. Rep. 2018 8 6483 10.1038/s41598-018-24762-9 29691437 [205] Zabel F Mohanan D Bessa J Link A Fettelschoss A Saudan P Kündig T M Bachmann M F Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies J. Immunol 2014 192 5499 5508 10.4049/jimmunol.1400065 24821969 [206] Gomes A C Mohsen M Bachmann M F Harnessing nanoparticles for immunomodulation and vaccines Vaccines 2017 5 6 10.3390/vaccines5010006 28216554 [207] Kanekiyo M Wei C J Yassine H M McTamney P M Boyington J C Whittle J R R Rao S S Kong W P Wang L S Nabel G J Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies Nature 2013 499 102 106 10.1038/nature12202 23698367 [208] Kang Y F Sun C Zhuang Z Yuan R Y Zheng Q B Li J P Zhou P P Chen X C Liu Z Zhang X Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates ACS Nano 2021 15 2738 2752 10.1021/acsnano.0c08379 33464829 [209] Bruun T U J Andersson A M C Draper S J Howarth M Engineering a rugged nanoscaffold to enhance plug-and-display vaccination ACS Nano 2018 12 8855 8866 10.1021/acsnano.8b02805 30028591 [210] Hsia Y Bale J B Gonen S Shi D Sheffler W Fong K K Nattermann U Xu C Huang P-S Ravichandran R Corrigendum: Design of a hyperstable 60-subunit protein icosahedron Nature 2016 540 150 10.1038/nature20108 [211] Bale J B Gonen S Liu Y X Sheffler W Ellis D Thomas C Cascio D Yeates T O Gonen T King N P Accurate design of megadalton-scale two-component icosahedral protein complexes Science 2016 353 389 394 10.1126/science.aaf8818 27463675 [212] Babapoor S Neef T Mittelholzer C Girshick T Garmendia A Shang H W Khan M I Burkhard P A novel vaccine using nanoparticle platform to present immunogenic M2e against avian influenza infection Influenza Res. Treat. 2011 2011 126794 23074652 [213] Champion C I Kickhoefer V A Liu G C Moniz R J Freed A S Bergmann L L Vaccari D Raval-Fernandes S Chan A M Rome L H A vault nanoparticle vaccine induces protective mucosal immunity PLoS One 2009 4 e5409 10.1371/journal.pone.0005409 19404403 [214] Hu H Steinmetz N F Development of a virus-like particle-based anti-HER2 breast cancer vaccine Cancers 2021 13 2909 10.3390/cancers13122909 34200802 [215] Wang W J Liu Z D Zhou X X Guo Z Q Zhang J Zhu P Yao S Zhu M Z Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy Nanomed. Nanotechnol. Biol. Med. 2019 16 69 78 10.1016/j.nano.2018.11.009 [216] Rad-Malekshahi M Fransen M F Krawczyk M Mansourian M Bourajjaj M Chen J Ossendorp F Hennink W E Mastrobattista E Amidi M Self-assembling peptide epitopes as novel platform for anticancer vaccination Mol. Pharm. 2017 14 1482 1493 10.1021/acs.molpharmaceut.6b01003 28088862",
  "plain_text": "Proteins have been widely used in the biomedical field because of their well-defined architecture, accurate molecular weight, excellent biocompatibility and biodegradability, and easy-to-functionalization. Inspired by the wisdom of nature, increasing proteins/peptides that possess self-assembling capabilities have been explored and designed to generate nanoassemblies with unique structure and function, including spatially organized conformation, passive and active targeting, stimuli-responsiveness, and high stability. These characteristics make protein/peptide-based nanoassembly an ideal platform for drug delivery and vaccine development. In this review, we focus on recent advances in subsistent protein/peptide-based nanoassemblies, including protein nanocages, virus-like particles, self-assemblable natural proteins, and self-assemblable artificial peptides. The origin and characteristics of various protein/peptide-based assemblies and their applications in drug delivery and vaccine development are summarized. In the end, the prospects and challenges are discussed for the further development of protein/peptide-based nanoassemblies."
}
